Page last updated: 2024-08-23

pravastatin and Drug Withdrawal Symptoms

pravastatin has been researched along with Drug Withdrawal Symptoms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, NC; Lee, TM; Lin, MS; Tsai, CH	1
Bax, JJ; Davignon, J; Dunkelgrun, M; Feringa, HH; Hoeks, SE; Kastelein, JJ; Poldermans, D; Schouten, O; van Domburg, RT; Vidakovic, R; Welten, GM	1
Baggio, G; Cianci, V; Crepaldi, G; Martini, S; Muraca, M; Vilei, MT	1
Böhm, M; Hamm, CW; Heeschen, C; Laufs, U; Snapinn, S; White, HD	1
Bixler, EO; Kales, A; Manfredi, RL; Tyson, KL; Vgontzas, AN	1

Trials

3 trial(s) available for pravastatin and Drug Withdrawal Symptoms

Article	Year
Add-on and withdrawal effect of pravastatin on proteinuria in hypertensive patients treated with AT receptor blockers. Kidney international, 2005, Volume: 68, Issue:2 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Drug Interactions; Drug Resistance; Endothelin-1; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Lipids; Losartan; Male; Middle Aged; Pravastatin; Proteinuria; Substance Withdrawal Syndrome	2005
Effect of withdrawal of pravastatin on biliary lipid composition in humans. Atherosclerosis, 1996, Volume: 123, Issue:1-2 Topics: Adult; Anticholesteremic Agents; Bile; Bile Acids and Salts; Bile Ducts; Cholelithiasis; Cholesterol; Diet, Fat-Restricted; Double-Blind Method; Drainage; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Liver; Phospholipids; Pravastatin; Substance Withdrawal Syndrome; Triglycerides	1996
Effects of lovastatin and pravastatin on sleep efficiency and sleep stages. Clinical pharmacology and therapeutics, 1991, Volume: 50, Issue:6 Topics: Adult; Female; Humans; Lovastatin; Male; Pravastatin; Sleep; Sleep Stages; Substance Withdrawal Syndrome	1991

Other Studies

2 other study(ies) available for pravastatin and Drug Withdrawal Symptoms

Article	Year
Effect of statin withdrawal on frequency of cardiac events after vascular surgery. The American journal of cardiology, 2007, Jul-15, Volume: 100, Issue:2 Topics: Aged; Atorvastatin; Electrocardiography; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Pravastatin; Pyrroles; Simvastatin; Substance Withdrawal Syndrome; Troponin T; Vascular Surgical Procedures	2007
Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation, 2002, Mar-26, Volume: 105, Issue:12 Topics: Acute Disease; Cholesterol; Clinical Trials as Topic; Comorbidity; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lovastatin; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Pravastatin; Proportional Hazards Models; Risk Factors; Simvastatin; Substance Withdrawal Syndrome; Survival Rate; Treatment Outcome; Troponin; United States	2002

Article

Year

Effect of statin withdrawal on frequency of cardiac events after vascular surgery.

The American journal of cardiology, 2007, Jul-15, Volume: 100, Issue:2

Topics: Aged; Atorvastatin; Electrocardiography; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Pravastatin; Pyrroles; Simvastatin; Substance Withdrawal Syndrome; Troponin T; Vascular Surgical Procedures

2007

Withdrawal of statins increases event rates in patients with acute coronary syndromes.

Circulation, 2002, Mar-26, Volume: 105, Issue:12

Topics: Acute Disease; Cholesterol; Clinical Trials as Topic; Comorbidity; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lovastatin; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Pravastatin; Proportional Hazards Models; Risk Factors; Simvastatin; Substance Withdrawal Syndrome; Survival Rate; Treatment Outcome; Troponin; United States

2002